Bracco Diagnostics of Princeton, NJ, has been awarded a contract by group purchasing organization Amerinet.
Under terms of the agreement, Bracco's injectable contrast media products will be made available to Amerinet members via a single contract through 2008, the company said.
The contract includes Isovue (iopamidol injection); MultiHance (gadobenate dimeglumine) injection, 529 mg/mL; ProHance (gadoteridol) injection, 279.3 mg/mL; and Bracco's ionic product line.
By AuntMinnie.com staff writers
January 26, 2006
Related Reading
Bracco to sell Esaote, January 23, 2006
Esaote rolls out Picus-Just 4D ultrasound, November 11, 2005
Bracco, Toshiba partner in 64-slice CTA trial, July 13, 2005
FDA OKs expanded use for Kinevac, June 1, 2005
Consorta selects Bracco, May 26, 2005
Copyright © 2006 AuntMinnie.com
